New details have emerged about what Regeneron is planning for the Saratoga Springs site it acquired last year.

The condition, which most often affects people in warm, humid climates where fungal spores are common, can trigger nasal ...

REGN stock is presently trading nearly 38% lower than its 1-year peak, and is also being traded at a P/S multiple that is ...

Regeneron Pharmaceuticals (REGN) shares have been in focus recently, attracting investor interest thanks to their steady ...

Merck said Saturday its new pill — a potential rival to Regeneron and Amgen — lowered stubbornly high cholesterol by almost ...

Regeneron will be responsible for funding preclinical, clinical and commercial development for any ModeX product it chooses to advance from the research pact, with ModeX eligible for milestone ...

Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in ...

Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand for its eczema treatment, Dupixent, and cancer treatment Libtayo, sending shares up ...

Prospera Financial Services acquires Regeneron Pharmaceuticals (REGN) shares, reflecting healthcare sector activity aligned ...

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal ...

A large group of seniors at Ardsley High School has entered the 2025 Regeneron Science Talent Search, the nation’s oldest and ...

Federal enforcement of the False Claims Act (FCA) against healthcare and pharmaceutical companies—especially based on alleged ...